Upstream
TinyFishby TinyFish · Primary-source research
LIVE · Sep 9, 2026, 06:28 ET
Company read

Moderna, Inc.

MRNA
Direction score
was 51 · +0 vs prior scan
51
▲ Holding
Customer Sentiment 40%
68
Workforce 30%
38
Leadership 20%
35
Product / Ops 10%
no source
Components are live; families with no completed source are excluded and weights renormalize.

What moved since the last scan

vs scan of Aug 24 · 16 days ago
Signal
Move
The evidence behind it
Nothing moved between the last two scans — that is itself a read.
edgar filings
115 filings, 12mo
Officer change filed 2026-07-08 (8-K Item 5.02), 47 days ago.

Supporting evidence, verbatim

Every quote links to its source and its scrape.
Quote
Source
Date
Scraped
Form 8-K, Items 5.02,7.01,9.01 — filed 2026-07-08
Jul 8
16d ago
Moderna said it plans to slash roughly 10% of its global workforce by the end of the year
Jul 31
16d ago
Moderna said on Thursday that it plans to cut about 10% of its global workforce by the end of 2025
Jul 31
16d ago
Moderna CEO Stephane Bancel said the company expects to have fewer than 5,000 workers by the end of the year.
Jul 31
16d ago
Every effort was made to avoid affecting jobs
Jul 31
16d ago
Still way too early to say “mRNA cancer vaccines are solved,” though.
16d ago
I’ve been holding since 2021 at $185 a share, considering breaking even or riding it higher. I don’t think it’s unlikely we see $300 in the next few years.
16d ago
A lot of people wrote Moderna off as a pandemic relic, but if you look at Moderna, they completed their IPO in 2018 and received their first approval in 2020.
16d ago
Neutral rating remains, but PT raised to $120.
16d ago
Everyone had written it off, left it for dead.
16d ago
I’m not sure it’s done. Another short attack is happening
16d ago
The stock is going to 300.
16d ago